Vasopressor · Alpha agonist
Ephedrine
Indications
- Hypotension in the setting of anesthesia (label), especially after induction or neuraxial block
- Hypotension with bradycardia, where its β1 effect helps and phenylephrine's reflex slowing would not
- Spinal hypotension at cesarean delivery when the mother is bradycardic; otherwise phenylephrine is preferred
- Brief hypotension in the ED or ICU while an infusion is prepared (off-label outside anesthesia)
Dosing
| Where | Dose |
|---|---|
| Blood pressure boluses | Ephedrine: 5–10 mg IV every 5–10 min (anesthesia) |
Mechanism of action
Ephedrine is a mixed-acting sympathomimetic. Most of its effect is indirect: it enters sympathetic nerve terminals through the norepinephrine transporter, displaces norepinephrine from storage vesicles and releases it onto α1 and β1 receptors. It is also a weaker direct agonist at α and β receptors. Because the indirect effect depends on releasable stores, repeated doses deplete them and each dose does less (tachyphylaxis).
Pharmacology
- Cardiovascular: raises heart rate, contractility and cardiac output, with a smaller rise in SVR, like a weak, long-acting epinephrine
- CNS: crosses the blood–brain barrier: alertness, restlessness, insomnia
- Respiratory: mild β2 bronchodilation
- Other: crosses the placenta (umbilical vein to maternal ratio 1.13) and raises fetal metabolism, lowering fetal pH (Ngan Kee 2009)
- Other: urinary retention from α1 tone at the bladder neck
Pharmacokinetics
| Onset | Within about 1 min IV |
|---|---|
| Duration | Pressor effect up to about 1 h after an IV bolus, depending on dose |
| Half-life | About 3 h in acidic urine to 6 h in alkaline urine (UK SmPC); US labels cite about 6 h |
| Distribution | Crosses the blood–brain barrier and placenta; present in breast milk |
| Metabolism | Little; a small fraction becomes active norephedrine |
| Elimination | About 77% unchanged in urine: 73–99% in acidic and 22–35% in alkaline urine (UK SmPC) |
Chemistry
- A phenylethylamine with no ring hydroxyls, plus β-hydroxyl, α-methyl and N-methyl groups: without a catechol COMT cannot act, and the α-methyl blocks MAO, so it works orally and lasts far longer than catecholamines
- Two chiral centers and four stereoisomers; the drug is (1R,2S)-(−)-ephedrine, and pseudoephedrine is its (1S,2S) diastereomer
- Originally from the plant Ephedra sinica (ma huang); now made synthetically
- Amine pKa about 9.6 (PubChem): ionized at pH 7.4, but lipophilic enough without ring hydroxyls to enter the brain
- Salt matters: ephedrine sulfate 50 mg equals 38 mg base; 50 mg/mL vials must be diluted; ready-to-use 5 mg/mL vials and syringes, pH 4.5–7.0, preservative-free (labels)
Adverse effects and cautions
In the one-pagers
Practice Mental Health: Meds and Communication questions free51 exam-style questions with rationales on the topic where Ephedrine comes up most. No account or download needed.
Other vasopressor drugs
Practice free in your browser3,800+ exam-style questions with rationales. No account, no ads. Also free on the App Store and Google Play.
Sources
- FDA label: Emerphed (2021)
- UK SmPC: ephedrine hydrochloride (2024)
- Ngan Kee 2009 (placental transfer)
- PubChem: ephedrine
For education and exam preparation only. Follow your institution’s protocols. Typical adult values for study. Follow the order, the label and your institution's protocols.